News Summary:
SAN DIEGO, Feb. 26, 2024 /PRNewswire/ -- Pittcon 2024 – Waters Corporation (NYSE:WAT) announced HPLC CONNECT software, an all-in-one software platform that enables full digital synchronization between Waters high- and ultra-performance liquid chromatography (HPLC/UPLC) systems and multi-angle light-scattering instruments (MALS) from its Wyatt Technology™ portfolio. The software delivers ease-of-use, greater efficiency, and higher confidence for scientists performing size exclusion chromatography and MALS (SEC-MALS) analyses for complex and critical biopharmaceutical innovations, including antibody drug conjugates, other complex protein conjugates, and gene therapies.
"Drug development scientists today are working with novel modalities that require advanced and comprehensive measurements for the development of new and potentially life-saving biologic drugs," said Fraser McLeod, Vice President, General Manager, QA/QC and Wyatt Technology, Waters Corporation. "The team delivered this product integration ahead of schedule to greatly simplify the characterization of complex molecules – a critical step in developing biologics. Waters HPLC CONNECT software removes a significant amount of labor, reduces risk of human error, and delivers unmatched confidence in the data generated during analysis."
HPLC CONNECT software supports select Waters™ LC systems including the ACQUITY™ Premier, Arc Premier, and Arc Systems. The software enables users to control and monitor HPLC modules including pumps, column ovens, UV detectors, and autosamplers from a single dashboard view.
Waters offers a full line of SEC columns optimized for separation of biomolecules by size, ideal for monoclonal antibodies, proteins, peptides, and other biologics.
Waters HPLC CONNECT software is now available globally.
Additional Resources
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 8,000 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Waters, HPLC CONNECT, Wyatt Technology, and ACQUITY are trademarks of Waters Technologies Corporation.
Contact:
Janice Foley
Senior Public Relations Manager
Waters Corporation
This email address is being protected from spambots. You need JavaScript enabled to view it.
+1.617.823.5555
Last Trade: | US$368.16 |
Daily Change: | 7.53 2.09 |
Daily Volume: | 1,302,652 |
Market Cap: | US$21.860B |
November 07, 2024 November 01, 2024 October 10, 2024 October 08, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB